Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Testicular cancer.

Gary R MacVicar1, Kenneth J Pienta

  • 1University of Michigan Medical Center, Ann Arbor, Michigan, USA.

Current Opinion in Oncology
|April 8, 2004
PubMed
Summary
This summary is machine-generated.

Recent testicular cancer research highlights a birth-cohort effect on incidence and identifies prognostic markers. Treatment strategies are evolving, with radiation and carboplatin showing efficacy, and surveillance being an option for early-stage disease.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Therapy for Stage IV Non-Small Cell Lung Cancer Without Driver Alterations: ASCO Living Guideline, 2026.3.1.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026
Same author

Therapy for Stage IV Non-Small Cell Lung Cancer With Driver Alterations: ASCO Living Guideline, 2026.3.0.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026
Same author

Therapy for Stage IV Non-Small Cell Lung Cancer Without Driver Alterations: ASCO Living Guideline, 2026.3.0.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026
Same author

Temporal myc dynamics permit mitotic bypass, promoting polyploid phenotypes.

Cancer letters·2025
Same author

Incidental discovery of gastrointestinal stromal tumor via PSMA-PET/CT imaging: Insights from a case report.

Urology case reports·2025
Same author

Punctuational evolution is pervasive in distal site metastatic colonization.

Proceedings. Biological sciences·2025
Same journal

Artificial intelligence-augmented robotic surgery in gynecologic oncology: intraoperative assistance and analytics.

Current opinion in oncology·2026
Same journal

Artificial intelligence in cervical cancer screening and triage: a role-stratified systematic review and bivariate meta-analysis.

Current opinion in oncology·2026
Same journal

Deep learning assisting the surgical management of gynecologic cancers.

Current opinion in oncology·2026
Same journal

Pain management in pancreatic cancer: time to change our strategy!

Current opinion in oncology·2026
Same journal

Systemic radionuclide treatments in gastro-entero-pancreatic neuroendocrine tumours.

Current opinion in oncology·2026
Same journal

5-Fluorouracil at seventy: still attractive but barely understood. A cautionary tale for drug development.

Current opinion in oncology·2026
See all related articles

Area of Science:

  • Oncology
  • Urology

Background:

  • Testicular cancer incidence is increasing, potentially due to early life exposures.
  • Prognostic markers are being investigated to better stratify patients.

Purpose of the Study:

  • To review recent clinically relevant literature on testicular cancer.
  • To summarize advancements in understanding incidence, prognosis, and treatment.

Main Methods:

  • Literature review of recent studies on testicular cancer.
  • Analysis of findings related to incidence, molecular markers, treatment efficacy, and surveillance.

Main Results:

  • Increased incidence linked to birth-cohort effects and early exposure.
  • Proliferation markers, apoptosis markers, and serum lactate dehydrogenase isoenzyme 1 (S-LD-1) show prognostic value.

Related Experiment Videos

  • Radiation is effective for Stage I/II seminoma; adjuvant carboplatin is an alternative for Stage I.
  • Post-chemotherapy CT findings do not rule out residual tumor; surveillance is viable for compliant early-stage patients.
  • Risk factors for bleomycin pulmonary toxicity are proposed; fertility remains a concern.

    • Conclusions:

    • Ongoing research refines testicular cancer therapies.
    • Improved understanding of molecular basis and risk stratification aims to reduce treatment-related toxicity.